Articles tagged with Covid 19 Vaccines
A new UCLA-led study found that individuals with traditional cultural values tend to take stricter COVID-19 precautions globally, with 21 of 27 countries showing a strong link between the two. In contrast, factors like distrust of science and concerns about the economy in the US suppressed cautionary behavior among social conservatives.
A new study found that a handful of key Twitter influencers effectively countered vaccine misinformation and promoted accurate information about vaccines. Social media influencers can use their social capital to challenge the spread of conspiracy theories.
A national survey found that South Carolina residents were more hesitant to receive COVID-19 vaccines due to low confidence in public health scientists and collective responsibility. Researchers hope that targeted education efforts will address these factors and reduce vaccine hesitancy.
A Rutgers study finds that individuals who avoid COVID-19 precautions are more likely to buy firearms, especially those with liberal or moderate political views. These groups also tend to trust less scientific information and have concerns about physical attacks, leading them to prioritize firearm ownership as a means of self-protection.
Researchers at Weill Cornell Medicine have identified an antibody that blocks infection by all dominant COVID-19 variants, including Omicron. The discovery could lead to new antibody-based treatments and more effective vaccines.
A study led by ISGlobal found that exposure to air pollution before the pandemic was associated with lower antibody responses to COVID-19 vaccines, particularly in uninfected individuals. The study measured IgM, IgG, and IgA antibodies in participants exposed to fine particulate matter, nitrogen dioxide, and black carbon.
Researchers at the University of Chicago have found that adding small molecules called immunomodulators to vaccine adjuvants can regulate the body's response to vaccines, reducing negative side effects. The study increased antibody response in flu vaccine models and reduced inflammation in typhoid vaccine models.
A UCLA study found that individuals who support the Black Lives Matter movement tend to be less hesitant about receiving COVID-19 vaccines. The researchers suggest that altruistic feelings about interactions between different social groups may account for this phenomenon.
A recent US study found that people living with HIV performed worse on cognitive tests after SARS-CoV-2 infection compared to those without HIV, but these differences were attributable to HIV rather than COVID-19. However, vaccinated individuals experienced declines in processing speed following COVID-19.
New research from Washington University School of Medicine reveals that updated booster shots targeting specific COVID-19 variants can elicit a broad antibody response capable of neutralizing new variants. Periodic boosters may be necessary to maintain population immunity as the virus continues to evolve.
A new live attenuated SARS-CoV-2 vaccine administered through the nose has shown better immunity than injected vaccines in hamster models, reducing transmissibility. The vaccine stimulates local immunity by activating antibody immunoglobulin A and memory T cells, providing early protection against COVID-19.
Researchers found that lipid nanoparticles stimulate innate immune cells more efficiently in younger individuals, but less so in older adults. The study suggests that understanding the immune response to LNPs can help develop strategies to improve vaccine responses in the aged population.
A WPI-led team used computational modeling to create a detailed picture of the SARS-COV-2 virus envelope, revealing its elliptical shape and changing structure. This discovery could lead to more effective therapies and vaccines, as well as a better understanding of the virus's properties.
A new analysis shows that the US has substantially higher death rates at all but the oldest ages compared to five high-income European countries. The excess death gap widened during the Covid-19 pandemic, with the number of excess deaths nearly doubling between 2019 and 2021.
Research found increased trust in scientists during COVID-19 pandemic, with polarized attitudes emerging, influencing behavior and vaccine adoption. Those with initial positive views became even more positive, while those with negative views became more entrenched.
Researchers found that COVID-19 vaccination generates robust T cell responses in haematology patients, on par with healthy individuals. The study provides key insights for future immunisation strategies and shows that mRNA vaccines can elicit strong T cell immunity in patients with co-morbidities.
Research finds COVID-19 vaccine fatigue is driven by confidence in institutions and communication campaigns, with positive incentives boosting willingness among partially vaccinated groups. Effective strategies include adapted vaccines, low-barrier access, and expert consensus.
A small molecule discovered by University of Houston researchers could potentially shorten the course of SARS-CoV-2 infection, offering a new alternative treatment option for COVID-19. The compound, CD04872SC, has shown promise in neutralizing the virus and its variants Delta and Omicron.
Researchers examine how chronological and biological age impact vaccine effectiveness, finding that both factors influence immune system capacity to mount responses. The study highlights the need for further research into 'immune aging' risk and departures from healthy aging.
A study found that socially vulnerable populations have poorer COVID-19 outcomes despite similar vaccine effectiveness, due to lower vaccination rates. The VISION Network analyzed electronic health record data and immunization records to highlight the need for targeted public health efforts on vaccine coverage.
A study of 1,678 participants found that low benefit expectations, negative experiences, and catastrophizing are associated with COVID-19 vaccination adverse effects. Clinician-patient interactions and public vaccine campaigns may be optimized by contextualizing information about vaccines.
Researchers at the University of Maryland School of Medicine are using mRNA vaccine technology to combat various infectious diseases. A new clinical trial aims to test an mRNA-based vaccine against malaria, with hopes for a rapid adaptive response to virus evolution and the manufacture of combination vaccines.
A recent study published in iScience has found that Covid-19 vaccination does not cause concerning changes to periods. Women who have been infected with the Covid-19 virus are at increased risk of menstrual changes such as missed or heavier periods.
The study found that vaccination significantly reduces the risk of long COVID, while factors such as being overweight, female, smoker, or over 40 increase the likelihood of developing the condition. Vaccination halves people's risk of developing long Covid
A systematic review and meta-analysis found demographic characteristics, comorbidities, and severe COVID-19 increase the risk of long COVID. Vaccination is protective against developing long COVID sequelae.
Researchers have identified a highly conserved region of the SARS-CoV-2 spike protein that could be targeted to boost human antibody responses against any coronavirus. The discovery could aid the development of more powerful antibody drugs and vaccines against COVID-19 and emerging coronaviruses.
A study published in Nature Immunology found that antibodies from previously infected patients can neutralize variants of the COVID-19 disease, including the Omicron variant. These broadly neutralizing antibodies have unique biochemical and structural features that enable them to block the virus from entering human cells.
A new study has found that SARS-CoV-2 infection damages the CD8+ T cell response, which is crucial for fighting the virus. Vaccination after infection can still provide protection, but booster shots may be needed to boost immune-cell responses.
A new study by Boston University School of Public Health reveals a 104% increase in pregnancy-related deaths among American Indian/Alaska Native people, with rates nearly doubling from pre-pandemic levels. The Delta and Omicron variants contributed to the worsening burden of mortality, particularly among racial and ethnic minorities.
A Kaiser Permanente study found that receiving Paxlovid within 5 days of COVID-19 symptoms significantly reduced the risk of hospital admission or death. The medication was effective in people with prior immunity and all ages.
The study found that COVID-19 mRNA vaccine effectiveness decreased with time since the last dose, while booster doses increased protection. The findings suggest that vaccination strategies should prioritize boosters to maintain protection against severe illness.
A multi-state study found COVID-19 mRNA vaccines remain protective during Omicron BA.4/BA.5 predominance, with estimated vaccine effectiveness of 68% against hospitalization within 7-119 days post-vaccination.
A new study describes an optimized method for isolating and identifying nanobodies targeting SARS-CoV-2, which could lead to the development of effective therapies. The approach uses a yeast display method, reducing costs and time required for screening nanobody libraries.
A new meta-analysis found that sleeping fewer than six hours per night after COVID-19 vaccination was associated with a weakened antibody response. The study highlights the need for simple behavioral interventions like sufficient sleep to improve vaccine efficacy during the pandemic.
A small number of patients with acute myocarditis after COVID-19 vaccination showed signs of heart muscle inflammation, while asymptomatic patients had normal cardiac tissue. The study suggests that symptoms alone are a poor indicator of myocardial injury after vaccination.
A University of Gothenburg study reveals that dementia is the dominant risk factor for COVID-19 infection and mortality among residents of Swedish nursing homes. Early-onset dementia was found to be the strongest association with increased mortality rates, particularly in the 65–75 age group.
Axillary lymphadenopathy after a COVID-19 vaccine booster dose resolves at a mean of 102 days. Findings support follow-up intervals of at least 12 weeks to avoid delaying screening mammography for suspected vaccine-related lymphadenopathy.
Researchers found that trust in federal, state, and local public health agencies was driven by beliefs in scientific expertise and provision of direct care, not control of outbreaks. Lower trust was related to concerns about conflicting recommendations and perceived political influence.
A recent study found that anxiety about contracting COVID-19 is a significant predictor of vaccine hesitancy. However, proactive coping, a trait involving future planning, also plays a surprising role in vaccine hesitation, amplifying it at both ends of the spectrum.
A study found that a commercial water purifier may have caused Mycobacterium abscessus infections in 4 cardiac surgery patients due to chlorine depletion. The hospital's water system was contaminated via municipal water, emphasizing the importance of monitoring and preventing mycobacteria.
A 21-person commission of public health experts calls for networked communities sharing accurate vaccine information to counter misinformation. The US has seen a surge in anti-vaccine activism, leading to vaccine hesitancy and increased illnesses.
A new study shows that patients with liver cirrhosis have a lower immune response to COVID-19 vaccines, but this does not affect the vaccines' effectiveness. Age, type of vaccine, and viral hepatitis etiology also play a role in immune responses.
A recent study found that public investment in critical research contributed significantly to the development of mRNA COVID-19 vaccines. The US government invested at least $337 million in research over 35 years, including basic science and vaccine development.
The US government invested at least $337 million in critical research leading to mRNA COVID-19 vaccines before the pandemic, and $31.6 billion during it. These public investments saved millions of lives and have potential to address future pandemics and treat other diseases.
A study published in npj Vaccines found that clear communication strategies, such as emphasizing self-interest and common ground, can increase vaccination solidarity among citizens. The researchers recommend a crisis communication approach that highlights the risks of vaccine nationalism and promotes long-term profit orientation.
Researchers identify 32 human monoclonal antibodies that can block SARS-CoV-2, SARS-CoV-1, and MERS-CoV coronaviruses. These antibodies target a vulnerable site on the viral spike protein, offering potential for broad protection against future pandemics.
A study of 1.65 million BNT162b2 vaccinations among Ontario adolescents found a rare but significant risk of myocarditis or pericarditis. The researchers emphasize that while the events are uncommon, they should be weighed against the benefits of COVID-19 vaccination.
Researchers at Arizona State University describe an innovative therapy using transient expression in tobacco plants to produce a monoclonal antibody against SARS-CoV-2. This class 4 mAb provides key advantages over existing treatments, including mutation resistance and universal protection against emerging variants.
Researchers have found that the naturally occurring amino acid ALA can reduce the expression of ACE2 on cell membranes, potentially lowering SARS-CoV-2's infectious capabilities. The study also reveals an underlying mechanism involving the production of heme, which is boosted by co-administering ALA with an iron source.
A new Australian study found fundamental differences in how the AstraZeneca and Pfizer COVID-19 vaccines impact the immune system, with some people receiving more effective protection than others. The study revealed a potential explanation for the connection between the AstraZeneca vaccine and blood clotting cases.
An analysis of 13 million tweets suggests that celebrity tweets, particularly from politicians and news anchors, played a significant role in shaping public opinion on the COVID-19 pandemic in the US. The findings highlight the importance of monitoring social media activity to combat misinformation and promote health-protective behaviors.
A new study published in Vaccines found that individuals with a university degree were more likely to believe in the effectiveness of COVID-19 preventive measures. The research also revealed that people with higher education levels had lower levels of trust in scientific misinformation, highlighting the importance of education in shapi...
A US study found that COVID-19 vaccination is associated with a lower risk of cardiovascular events, particularly among those with comorbidities. Even partial vaccination was linked to a reduced risk of adverse cardiovascular events. The research suggests that vaccination may have beneficial effects on post-COVID-19 complications.
A study found that vaccinated people are less likely to have opportunistic pathogens in their nose and throat, and also experience milder symptoms of COVID-19. This is attributed to the presence of transcriptionally active nasopharyngeal commensals, which play a key role in defining mild symptoms.
Researchers found that interactive simulation formats were more effective than conventional text-based formats in convincing vaccine-hesitant adults to get vaccinated. The study suggests that interactive simulations can boost people's decision-making competence, leading to positive changes in vaccination intentions and benefit-to-harm ...
A comprehensive review and meta-analysis published in The Lancet suggests that natural immunity from COVID-19 infection provides significant protection against hospitalization, symptomatic disease, and severe illness for at least 10 months. However, this protection declines over time, with an estimated 85% protection rate at one month ...
A new Northwestern University study suggests that COVID-19 boosters may be less effective due to pre-existing antibodies from initial vaccinations. The study found that these antibodies can rapidly clear the booster from the body, limiting its efficacy. Increasing time between vaccinations is also beneficial for the immune response.
Researchers found a significant increase in new-onset diabetes after COVID-19 infection, with vaccination prior to infection showing protective effects. The study suggests that COVID-19 infection could be acting as a disease accelerator, amplifying risk for diabetes diagnosis.
Researchers estimated that three doses of Comirnaty and CoronaVac vaccines were 48% and 30% effective, respectively, in preventing Omicron infection. Boosters improved efficacy to 69% and 56%, but protection waned over time.
A recent study published in JAMA Network Open found that COVID-19 vaccination significantly reduces the risk of developing new-onset diabetes following an infection. The research suggests a notable benefit of vaccination in protecting against this complication.